Modulation of HLA-DR expression on retroocular fibroblasts from patients with active thyroid-related ophthalmopathy: in vitro effects of agents used in the management of hyperthyroidism and ophthalmopathy.
Heufelder
A E
AE
Department of Internal Medicine, Mayo Clinic/Foundation, Rochester, Minnesota.
Gorman
C A
CA
Bahn
R S
RS
D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D005123:Eye / Q000276:immunology*; D005347:Fibroblasts / Q000276:immunology; D015870:Gene Expression / Q000187:drug effects; D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology*; D006684:HLA-DR Antigens / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology
D006684:HLA-DR Antigens; D003907:Dexamethasone; D007371:Interferon-gamma; D016572:Cyclosporine; D007213:Indomethacin